Acetaminophen, aspirin and progression of advanced chronic kidney disease
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although many studies have investigated the possible association between analgesic use (acetaminophen and aspirin) and the development of chronic kidney disease (CKD), the effect of analgesics on the progression of established CKD of any cause has not yet been investigated. METHODS: In this population-based Swedish cohort study, we investigated the decline over 5-7 years in estimated glomerular filtration rate (eGFR) among 801 patients with incident, advanced CKD (serum creatinine >3.4 mg/dL for men, >2.8 mg/dL for women for the first time) and with different analgesic exposures. Lifetime analgesic use and current regular use were ascertained through in-person interviews at inclusion while data on analgesic use during the follow-up was abstracted from the medical records at the end of the study period. A linear regression slope, based on their eGFR values during the follow-up, provided a summary of within-individual change. In the final multivariate analyses, a linear mixed effects model was implemented to assess the relation of analgesic use and change in eGFR over time. RESULTS: The progression rate for regular users of acetaminophen was slower than that for non-regular users (regular users progressed 0.93 mL/min/1.73 m(2) per year slower than non-regular users; 95% CI 0.03, 1.8). For regular users of aspirin, the progression rate was significantly slower than that for non-regular users (regular users progressed 0.80 mL/min/1.73 m(2) per year slower than non-regular users; 95% CI 0.1, 1.5). Different levels of lifetime cumulative dose of acetaminophen and aspirin did not significantly affect the progression rate. CONCLUSION: We suggest that single substance acetaminophen and aspirin may be safe to use by patients with diagnosed advanced CKD stage 4-5 without an adverse effect on the progression rate of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Self-citationHow to measure comorbiditya critical review of available methods
DEGROOT, V, BECKERMAN, H., LANKHORST, G., & BOUTER, L. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00585-1 · Cited by 1,757 · cited 1×
“follow-up studies [22], including studies of patients with end-stage renal disease [23].”
BackgroundEfficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
Hou, F. F., Zhang, X., Zhang, G. H., Xie, D., Chen, P. Y., Zhang, W. R., Jiang, J. P., Liang, M., Wang, G. B., Liu, Z. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053107 · Cited by 710 · cited 1×
“Progression rates have been measured in other cohorts of patients with CKD as severe as in our study [31,32].”
ResultPerneger, T. V., Whelton, P. K., & Klag, M. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412223312502 · Cited by 484
Research works printed but not linked: 31
- Spuhler, 1953, Zeitschrift f r klinische Medizin, 151, 1
- Hagtvet, 1963, Acta medica Scandinavica, 174, 1, 10.1111/j.0954-6820.1963.tb07886.x · doi:10.1111/j.0954-6820.1963.tb07886.x
- Dubach, 1983, New England Journal of Medicine, 308, 357, 10.1056/NEJM198302173080703 · DOI
- Sandler, 1989, New England Journal of Medicine, 320, 1238, 10.1056/NEJM198905113201903 · DOI · Paper page
- Pommer, 1989, American journal of nephrology, 9, 403, 10.1159/000168002 · DOI · Paper page
- Morlans, 1990, British journal of clinical pharmacology, 30, 717, 10.1111/j.1365-2125.1990.tb03841.x · DOI · Paper page
- Ib ez, 2005, Kidney international, 67, 2393, 10.1111/j.1523-1755.2005.00346.x · DOI
- Fored, 2001, New England Journal of Medicine, 345, 1801, 10.1056/NEJMoa010323 · DOI · Paper page
- Murray, 1983, Archives of Internal Medicine, 143, 1687, 10.1001/archinte.143.9.1687 · DOI
- Kurth, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation, 42, 234, 10.1016/S0272-6386(03)00647-4 · DOI
- Curhan, 2004, Archives of Internal Medicine, 164, 1519, 10.1001/archinte.164.14.1519 · DOI · Paper page
- Schwarz, 1989, Nephron, 53, 244, 10.1159/000185752 · doi:10.1159/000185752
- Hauser, 1991, Journal of clinical epidemiology, 44, 53, 10.1016/0895-4356(91)90200-S · DOI
- Mackinnon, 2003, Nephrology Dialysis Transplantation, 18, 1800, 10.1093/ndt/gfg230 · doi:10.1093/ndt/gfg230
- 2000, Journal of the American Society of Nephrology, 11, 155A
- Levey, 1999, Annals of Internal Medicine, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 · DOI · Paper page
- Charlson, 1987, Journal of chronic diseases, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
- van Manen, 2003, Journal of the American Society of Nephrology, 14, 478, 10.1097/01.ASN.0000043902.30577.C9 · DOI
- Peterson, 1995, Annals of Internal Medicine, 123, 754, 10.7326/0003-4819-123-10-199511150-00003 · DOI · Paper page
- Agodoa, 2001, JAMA, 285, 2719, 10.1001/jama.285.21.2719 · DOI · Paper page
- 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation, 39, 170, 10.1053/ajkd.2002.30946 · doi:10.1053/ajkd.2002.30946
- 2007, Journal of the American Society of Nephrology, 18, 2749, 10.1681/ASN.2007020199 · DOI · Paper page
- 2006, Journal of the American Society of Nephrology, 17, 2900, 10.1681/ASN.2005101106 · DOI
- 2007, Nephrology Dialysis Transplantation, 22, 3, 10.1093/ndt/gfl561 · DOI
- 2007, Nephrology Dialysis Transplantation, 22, 2909, 10.1093/ndt/gfm286 · DOI · Paper page
- Evans, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation, 46, 863, 10.1053/j.ajkd.2005.07.040 · DOI · Paper page
- 1982, CLINIC NEPHROL, 17, 134
- Rexrode, 2001, JAMA, 286, 315, 10.1001/jama.286.3.315 · DOI · Paper page
- Dubach, 1991, New England Journal of Medicine, 324, 155, 10.1056/NEJM199101173240304 · DOI · Paper page
- Elseviers, 1995, Kidney international, 48, 1912, 10.1038/ki.1995.491 · DOI
- Salas, 1999, American Journal of Epidemiology, 149, 981, 10.1093/oxfordjournals.aje.a009758 · DOI · Paper page
Cited by
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Paracetamol: not as safe as we thought? A systematic literature review of observational studies
Roberts, E., Delgado Nunes, V., Buckner, S., Latchem, S., Constanti, M., Miller, P., Doherty, M., Zhang, W., Birrell, F., Porcheret, M., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206914 · Cited by 412
Vassalotti, J. A., Centor, R., Turner, B. J., Greer, R. C., Choi, M., & Sequist, T. D. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.08.025 · Cited by 291
“Unlike NSAIDs, low-dose aspirin is not associated with acute kidney injury or rapid chronic kidney disease progression.(44)”
BackgroundClinical practice guideline on pregnancy and renal disease
Wiles, K., Chappell, L., Clark, K., Elman, L., Hall, M., Lightstone, L., Mohamed, G., Mukherjee, D., Nelson-Piercy, C., Webster, P., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1560-2 · Cited by 275
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“It was previously hypothesized that paracetamol may cause renal injury due to the reports of nephropathy after phenacetin overuse; however, this hypothesis was then rejected by further evidence.(90) Data show no association between paracetamol and acute renal failure in patients with chronic kidney disease.”
Result
Metadata
- Authors
- Evans, M., Fored, C. M., Bellocco, R., Fitzmaurice, G., Fryzek, J. P., McLaughlin, J. K., Nyren, O., & Elinder, C.-G.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-20
- Volume
- 24
- Issue
- 6
- Pages
- 1908-1918
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2149208599
- Cited by
- 67
- References
- 4
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acetaminophen, aspirin and progression of advanced chronic kidney disease. https://app.cochat.ai/papers/10.1093/ndt/gfn745
- The paper
- Evans, M., Fored, C. M., Bellocco, R., Fitzmaurice, G., Fryzek, J. P., McLaughlin, J. K., Nyren, O., & Elinder, C.-G. (2009). Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfn745
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.